Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.

@article{Koytak2010FluoresceinAP,
  title={Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.},
  author={Arif Koytak and Kazim Erol and Erol Coşkun and Nihal Asik and Hakan {\"O}zt{\"u}rk and Yusuf {\"O}zert{\"u}rk},
  journal={Retina},
  year={2010},
  volume={30 10},
  pages={1698-703}
}
PURPOSE The purpose of this study was to evaluate the results of fluorescein angiography-guided photodynamic therapy with half-dose verteporfin in the treatment of chronic central serous chorioretinopathy with focal leakage areas. METHODS Eight cases with a history of central serous chorioretinopathy of ≥6 months were included. All eyes had one or more focal areas of active retinal pigment epithelial leak. Photodynamic therapy was applied with half-dose verteporfin (3 mg/m²), and the spot… CONTINUE READING